Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis

  title={Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis},
  author={Simon B. Goldberg and Benjamin Shechet and Christopher R Nicholas and Chi Wing Ng and Geetanjali Deole and Zhuofan Chen and Charles L. Raison},
  journal={Psychological Medicine},
  pages={2655 - 2666}
Abstract Background Scientific interest in the therapeutic effects of classical psychedelics has increased in the past two decades. The psychological effects of these substances outside the period of acute intoxication have not been fully characterized. This study aimed to: (1) quantify the effects of psilocybin, ayahuasca, and lysergic acid diethylamide (LSD) on psychological outcomes in the post-acute period; (2) test moderators of these effects; and (3) evaluate adverse effects and risk of… 

Sustained effects of single doses of classical psychedelics in humans

The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of

Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis

Rationale: The benefits of mindfulness are well documented and it has become widely used in both clinical and general populations. The benefits of classic serotonergic psychedelics (e.g. psilocybin,

Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges

ABSTRACT Introduction A limited number of preliminary open-label (n = 3) and placebo-controlled clinical trials (n = 5) have suggested psilocybin and LSD as potential rapid antidepressants. In this

Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability

ABSTRACT Introduction Ayahuasca is a psychedelic brew originally used by Amazonian indigenous groups and in religious rituals. Pre-clinical and observational studies have demonstrated its possible

Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis

It is demonstrated that single- or two-dose psilocybin administration has rapid and sustained antidepressant effects for up to 6 months, with favorable cardiovascular safety and acceptability.

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Pre-clinical and clinical evidence of the acute and sustained therapeutic potential of psychedelic therapy in the context of a transdiagnostic dimensional systems framework is reviewed, focusing on the Research Domain Criteria (RDoC) as a template, to assist the field in moving toward a mechanistic understanding of how psychedelics work for patients.

Validation of a new instrument for assessing attitudes on psychedelics in the general population

The Attitudes on Psychedelics Questionnaire is valid, reliable, and could be applied in assessing educational interventions, patients’ treatment outcomes, and the attitudes of different groups of experts.

Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample

Investigating the association between lifetime classic psychedelic use and sick leave in the past 30 days among adults in the United States suggests that classic psychedelics could potentially lead to reduced sick leave and associated costs in the general population.

Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead

Research exploring the potential of psychedelic-assisted therapies to treat a range of mental illnesses is flourishing, after the problematic sociopolitical history of psychedelics led to the



Long-term effects of psychedelic drugs: A systematic review

Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis

This meta-analysis shows that psychedelic treatments were safe and could contribute to a rapid improvement of depressive symptoms.

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

The present findings reinforce the view that psychedelics elicit psychosis-like symptoms acutely yet improve psychological wellbeing in the mid to long term, and are proposed that acute alterations in mood are secondary to a more fundamental modulation in the quality of cognition.

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Overall, analyses support the efficacy of psychedelic-assisted therapy across four mental health conditions – post-traumatic stress disorder, anxiety/depression associated with a life-threatening illness, unipolar depression, and social anxiety among autistic adults.

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial

Evidence of rapid antidepressant effects of a single dosing session with ayahuasca when compared to placebo is observed, and this study is registered with (NCT02914769).

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

Results are promising, several studies were open label, and only few were RCTs, and most had small sample sizes and a short duration, but long-term studies are lacking.